IRIS
MONTECUCCO, FABRIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 46.794
Totale 46.794
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 46.794
Totale 46.794
Salva come PNG Salva come JPEG
Città #
Genova 36.573
Genoa 3.853
Rapallo 3.738
Vado Ligure 2.517
Bordighera 113
Totale 46.794
Salva come PNG Salva come JPEG
Nome #
Stairs instead of elevators at the workplace decreases PCSK9 levels in a healthy population 213
Regulation and Function of Extracellular Nicotinamide Phosphoribosyltransferase/Visfatin. 181
Early reduction of matrix metalloproteinase-8 serum levels is associated with leptin drop and predicts diabetes remission after bariatric surgery 176
Alamandine abrogates neutrophil degranulation in atherosclerotic mice 173
APO866 increases antitumor activity of cyclosporin - A by inducing mitochondrial and endoplasmic reticulum stress in leukemia cells 173
Autophagy in blood cancers: biological role and therapeutic implications. 172
C-reactive protein (CRP) induces chemokine secretion via CD11b/ICAM-1 interaction in human adherent monocytes. 171
Update on cardiotoxicity of anti-cancer treatments 171
Pathophysiology and treatments of oxidative injury in ischemic stroke: Focus on the phagocytic NADPH Oxidase 2 171
Gastric bypass in morbid obese patients is associated with reduction in adipose tissue inflammation via N-oleoylethanolamide (OEA)-mediated pathways. 170
Update on the Role of Neutrophils in Atherosclerotic Plaque Vulnerability. 168
The vulnerable coronary plaque: update on imaging technologies. 167
Effect of blockage of the endocannabinoid system by CB(1) antagonism on cardiovascular risk. 163
Reactive oxygen-induced cardiac intracellular pathways during ischemia and reperfusion. 163
C-Reactive Protein Levels at the Midpregnancy Can Predict Gestational Complications 163
CC chemokine CCL5 plays a central role impacting infarct size and post-infarction heart failure in mice. 161
Update on the role of cannabinoid receptors after ischemic stroke. 159
Reply to "Management of left ventricular thrombosis in patients with apical aneurysm". 159
Anti-apolipoprotein A-1 auto-antibodies as active modulators of atherothrombosis 159
Nephrotic syndrome in a patient with IgM myeloma with associated neutrophilia. 158
Immune complexes induce monocyte survival through defined intracellular pathways 158
CC and CXC chemokines are pivotal mediators of cerebral injury in ischaemic stroke. 157
An Oral Formulation of Angiotensin-(1-7) Reverses Corpus Cavernosum Damages Induced by Hypercholesterolemia. 156
Pathophysiological role of neutrophils in acute myocardial infarction. 154
Anemia Due to Inflammation in an Anti-Coagulated Patient with Blue Rubber Bleb Nevus Syndrome 154
Insulin primes human neutrophils for CCL3-induced migration: crucial role for JNK 1/2. 153
A9.11 Anti-apolipoprotein A1 autoantibodies induce tissue factor activity and expression: a role in atherothrombosis. 153
Mutation Analysis of PRKAR1A Gene in a Patient with Atrial Myxoma 153
5-fluorouracil causes endothelial cell senescence: Potential protective role of glucagon-like peptide 1 153
Update on the endocannabinoid-mediated regulation of gelatinase release in arterial wall physiology and atherosclerotic pathophysiology. 151
Levels of serum uric acid at admission for hypoglycaemia predict 1-year mortality 151
Atherosclerosis is an inflammatory disease. 150
Treatment with CB 2 Agonist JWH-133 Reduces Histological Features Associated with Erectile Dysfunction in Hypercholesterolemic Mice. 150
Role of matrix metalloproteinases in animal models of ischemic stroke. 150
Atherosclerosis in Rheumatoid Arthritis: Promoters and Opponents 150
Anti-apolipoprotein A-1 IgG predicts major cardiovascular events in patients with rheumatoid arthritis. 149
Angiotensin II receptor antagonists in acute coronary syndromes. 149
Treatment with recombinant tissue plasminogen activator (r-TPA) induces neutrophil degranulation in vitro via defined pathways. 148
The role of adipocytokines in atherogenesis and atheroprogression. 148
Dexamethasone-induced apoptosis of human monocytes exposed to immune complexes. Intervention of CD95-and XIAP-dependent pathways. 148
Systemic and intraplaque mediators of inflammation are increased in patients symptomatic for ischemic stroke. 147
Statins and stent thrombosis. 147
CB2 cannabinoid receptor agonist JWH-015 modulates human monocyte migration through defined intracellular signaling pathways. 147
An emerging role of glucagon-like Peptide-1 in preventing advanced-glycation-end-product-mediated damages in diabetes. 146
Treatment with apixaban in a patient with recent chronic subdural haematoma: a case report. 146
Elevated endocannabinoid plasma levels are associated with coronary circulatory dysfunction in obesity. 146
High baseline C-reactive protein levels predict partial type 2 diabetes mellitus remission after biliopancreatic diversion 145
Update on the Pathophysiological Activities of the Cardiac Molecule Cardiotrophin-1 in Obesity. 145
Diminazene enhances stability of atherosclerotic plaques in ApoE-deficient mice 145
Methylene blue: potential use of an antique molecule in vasoplegic syndrome during cardiac surgery. 144
Alpha-fetoprotein: A controversial prognostic biomarker for small hepatocellular carcinoma. 144
The activation of the cannabinoid receptor type 2 reduces neutrophilic protease-mediated vulnerability in atherosclerotic plaques. 144
Delayed apoptosis of human monocytes exposed to immune complexes is reversed by oxaprozin: role of the Akt/I kappaB kinase/nuclear factor kappaB pathway. 143
CB(2) cannabinoid receptor activation is cardioprotective in a mouse model of ischemia/reperfusion. 143
Nicotinamide Phosphoribosyltransferase (Nampt) Inhibitors As Therapeutics: Rationales, Controversies, Clinical Experience. 143
Human mesenchymal stem cells inhibit neutrophil apoptosis: A model for neutrophil preservation in the bone marrow niche. 143
Induction of neutrophil chemotaxis by leptin - Crucial role for p38 and Src kinases. 143
Potential pathophysiological role for the vitamin D deficiency in essential hypertension. 142
Single administration of the CXC chemokine-binding protein Evasin-3 during ischemia prevents myocardial reperfusion injury in mice. 141
Insulin resistance: a proinflammatory state mediated by lipid-induced signaling dysfunction and involved in atherosclerotic plaque instability? 140
Apelin-13 treatment enhances the stability of atherosclerotic plaques 140
Induction of cell killing and autophagy by amphiphilic pyrrolidine derivatives on human pancreatic cancer cells 140
Nicotinamide phosphoribosyltransferase inhibition reduces intraplaque CXCL1 production and associated neutrophil infiltration in atherosclerotic mice. 140
Coronary stenting: A matter of revascularization 139
Thrombin induces protease-activated receptor 1 signaling and activation of human atrial fibroblasts and dabigatran prevents these effects 139
Impact of Systemic Inflammation and Autoimmune Diseases on apoA-I and HDL Plasma Levels and Functions. 139
Cannabinoid receptors in acute and chronic complications of atherosclerosis. 138
Update on the role of Angiotensin in the pathophysiology of coronary atherothrombosis. 138
Anti-apoA-1 auto-antibodies increase mouse atherosclerotic plaque vulnerability, myocardial necrosis and mortality triggering TLR2 and TLR4 138
Myostatin mediates abdominal aortic atherosclerosis progression by inducing vascular smooth muscle cell dysfunction and monocyte recruitment 138
Anti-ApoA-1 IgG serum levels predict worse poststroke outcomes 137
Sepsis by Pasteurella multocida in an Elderly Immunocompetent Patient after a Cat Bite 137
Treatment with KLEPTOSE® CRYSMEB reduces mouse atherogenesis by impacting on lipid profile and Th1 lymphocyte response 137
Update on the treatments of non-alcoholic fatty liver disease (NAFLD). 136
The Role of the Intraplaque Vitamin D System in Atherogenesis. 136
Improving Reconstituted HDL Composition for Efficient Post-Ischemic Reduction of Ischemia Reperfusion Injury. 136
Update on statin-mediated anti-inflammatory activities in atherosclerosis. 136
Data regarding the effects of thrombin and dabigatran-inhibited thrombin on protease-activated receptor 1 and activation of human atrial fibroblasts 136
Statins in the treatment of acute ischemic stroke. 136
Acipimox reduces circulating levels of insulin and associated neutrophilic inflammation in metabolic syndrome. 136
Anti-Apolipoprotein A-1 auto-antibodies are active mediators of atherosclerotic plaque vulnerability 135
Does non-alcoholic fatty liver disease (NAFLD) increase cardiovascular risk? 135
Anti-apolipoprotein a-1 IgG levels predict coronary artery calcification in obese but otherwise healthy individuals. 135
Glucagon-Like Peptide-1 Secreting Cell Function as well as Production of Inflammatory Reactive Oxygen Species Is Differently Regulated by Glycated Serum and High Levels of Glucose. 135
Update on Inflammatory Biomarkers and Treatments in Ischemic Stroke 135
Evidence on the pathogenic role of auto-antibodies in acute cardiovascular diseases. 135
Inhibition of Nicotinamide Phosphoribosyltransferase Reduces Neutrophil-Mediated Injury in Myocardial Infarction. 135
The inflammatory response as a target to reduce myocardial ischaemia and reperfusion injury. 134
Update on the Pathophysiological Role of Intracellular Signaling Pathways in Atherosclerotic Plaques and Ischemic Myocardium. 134
Role of Neutrophils in Atherogenesis: an Update 134
Intraplaque Expression of C-Reactive Protein Predicts Cardiovascular Events in Patients with Severe Atherosclerotic Carotid Artery Stenosis 134
Glucose-targeted therapy for subjects with Type 2 Diabetes Mellitus: "Primum non nocere" 134
Statins, ACE inhibitors and ARBs in cardiovascular disease. 134
Pre-surgery age-adjusted Charlson Comorbidity Index is associated with worse outcomes in acute cholecystitis 134
Inflammation in the pathophysiology of essential hypertension. 133
Elevated E-selectin and diastolic blood pressure in diabetic children. 133
Sofosbuvir/velpatasvir: A promising combination 133
MELAS Syndrome with Cardiac Involvement: A Multimodality Imaging Approach 133
The immune response is involved in atherosclerotic plaque calcification: could the RANKL/RANK/OPG system be a marker of plaque instability? 133
Toll-like receptor 7 protects from atherosclerosis by constraining "inflammatory" macrophage activation. 132
Totale 14.742
Salva come PNG Salva come JPEG
Categoria #
all - tutte 149.855
article - articoli 145.864
book - libri 0
conference - conferenze 484
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 3.507
Totale 299.710
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202013.346 0 0 0 0 1.566 1.986 2.797 1.510 1.621 2.071 1.225 570
2020/20215.649 333 613 443 760 375 321 203 699 349 717 262 574
2021/20225.940 255 459 305 490 348 472 364 1.289 395 543 280 740
2022/20234.698 560 280 56 444 654 825 5 395 853 21 497 108
2023/20242.947 137 335 85 296 286 511 204 216 160 92 185 440
2024/20252.769 320 710 284 591 864 0 0 0 0 0 0 0
Totale 48.703